Purchase Order N0025923P0019
Award Date 11/7/22
Potential Completion Date 1/11/23
Potential Value $742K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Millcreek, UT 84107, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency (DOD) awarded a $746,778 firm fixed price purchase order contract to Biofire Defense LLC of Salt Lake City, Utah. The contract is for the delivery of 184 kits containing 30 tests each of Biofire Defense's RESPIRATORY PANEL 2.1 in vitro diagnostic test panels. The place of performance is Biofire Defense's facility in Salt Lake City and the period of performance runs from June 16, 2022 through September 14, 2022. The contract was awarded under the National Interest Action...
- The Defense Health Agency awarded a $828,024.90 firm fixed price delivery order to Biofire Defense LLC under an unspecified contract vehicle. The order is for respiratory panel testing services to support DHA programs. Work will be performed in Salt Lake City, Utah through December 31, 2021. The prime contractor will provide respiratory disease diagnostic panels to assist the Defense Health Agency in monitoring the health of military personnel. No subcontractors or set-aside designations were...
- This is a firm-fixed price purchase order awarded by the Defense Health Agency to Biofire Defense LLC, a for-profit limited liability company that manufactures biological threat detection and infectious disease diagnostics products. The contract is for the delivery of 62 kits of the Respiratory Panel 2.1 In Vitro Diagnostic (IVD) product, with a potential value of $239,743.46. The place of performance is Salt Lake City, Utah, and the completion date is October 28, 2022. The contract has no...
- The Bureau of Medicine and Surgery awarded a $102,344 firm fixed-price purchase order to Biofire Defense LLC on July 22, 2024, for FilmArray Respiratory Panels 2.1. The contract, which carries no set-aside designation, is scheduled for completion by September 30, 2025, with performance taking place in Peru. Biofire Defense LLC, a Salt Lake City-based limited liability company specializing in molecular diagnostic technologies, has established itself as a key federal vendor for infectious...
- The Defense Health Agency awarded a $141,750 firm-fixed-price purchase order to Biofire Defense LLC, a for-profit limited liability company and manufacturer of biological agent identification products. The contract is for the delivery of 30 units of the Respiratory Panel 2.1 IVD, a diagnostic product that supports biodefense and infectious disease testing. This award does not have a set-aside designation. Biofire Defense has previously received other federal contracts and grants related to...
- This federal contract award was made by the Bureau of Medicine and Surgery, a Defense agency, to Biofire Defense LLC, a for-profit limited liability company and manufacturer of goods. The $48,748.00 firm fixed price purchase order is for the delivery of a Respiratory Panel 2.1 IVD with 30 tests. The contract has an ultimate completion date of March 11, 2025. Biofire Defense LLC is a provider of biological agent identification products, including the Biofire FilmArray and RAZOR Mk II systems,...
- The U.S. Department of Defense's Joint Program Executive Office for Chemical and Biological Defense awarded a $156.8K firm fixed-price delivery order to Biofire Defense LLC on January 23, 2026, for the purchase of Global Fever Panel 6-Pouch Kits. The work will be performed in Salt Lake City, Utah, with an ultimate completion date of April 15, 2026. No set-aside designation was applied to this award. Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies...
- The Department of the Air Force awarded a definitive contract valued at $33.1 million to Biofire Defense LLC of Salt Lake City, Utah. The firm fixed price contract is to provide "COVID 19" BIOFIRE RESPIRATORY 2.1 (RP2.1) PANEL WITH SARS_COV-2 diagnostic testing kits compatible for use on BioFire 2.0, BioFire Torch, and other BioFire analyzers. The solicitation sought proposals to supply these BioFire Respiratory 2.1 panels to detect SARS-CoV-2 and 21 additional respiratory pathogens...
- This contract was awarded by the Defense Health Agency to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The award is for 40 respiratory panels at a firm fixed price of $162,285.00, to be delivered by October 15, 2021. The respiratory panels are used to detect respiratory pathogens, including SARS-CoV-2. This contract does not have a set-aside designation. Biofire Defense has previously provided diagnostic assays, test...
- The Bureau of Medicine and Surgery awarded a $18,034 firm fixed-price purchase order to Biofire Defense LLC on December 3, 2024, for the BIOFIRE DEFENSE PRODUCT NGDS-ASY-0017. The contract, which requires completion by February 28, 2025, will be performed in Frederick, Maryland. This purchase order represents a tactical procurement from Biofire Defense, a Salt Lake City-based manufacturer specializing in molecular diagnostic technologies and biological agent identification products. No set-aside...